Secondary Prevention for Atherosclerotic Cardiovascular Disease

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Scientific Statement From the American Heart Association Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults

Chen, Susan Cheng, Dalane W. Kitzman, Mathew S. Maurer, Michael W. Rich, Win-Kuang Jerome L. Fleg, Daniel E. Forman, Kathy Berra, Vera Bittner, James A. Blumenthal, Michael A. Scientific Statement From the American Heart Association Secondary Prevention of Atherosclerotic Cardiovascular Disease in Older Adults: A Print ISSN: 0009-7322. Online ISSN: 1524-4539 Copyright © 2013 American Heart Asso...

متن کامل

Low-dose colchicine for secondary prevention of cardiovascular disease.

OBJECTIVES The objective of this study was to determine whether colchicine 0.5 mg/day can reduce the risk of cardiovascular events in patients with clinically stable coronary disease. BACKGROUND The presence of activated neutrophils in culprit atherosclerotic plaques of patients with unstable coronary disease raises the possibility that inhibition of neutrophil function with colchicine may re...

متن کامل

Statins for Secondary Prevention of Cardiovascular Disease: The Right Dose

Since the publication of the 4S trial in 1994, there has emerged a consensus that statins save lives and decrease myocardial infarctions and strokes in coronary artery disease (CAD) patients irrespective of baseline serum cholesterol. However, there is controversy over the correct dose and the utility of the treatment-to-goal (cholesterol, low-density lipoprotein) approach. To answer remaining ...

متن کامل

Statins for secondary prevention of cardiovascular disease: the right dose.

Since the publication of the 4S trial in 1994, there has emerged a consensus that statins save lives and decrease myocardial infarctions and strokes in coronary artery disease (CAD) patients irrespective of baseline serum cholesterol. However, there is controversy over the correct dose and the utility of the treatment-to-goal (cholesterol, low-density lipoprotein) approach. To answer remaining ...

متن کامل

Statins for Secondary Prevention of Cardiovascular Disease: The Right Dose

Since the publication of the 4S trial in 1994, there has emerged a consensus that statins save lives and decrease myocardial infarctions and strokes in coronary artery disease (CAD) patients irrespective of baseline serum cholesterol. However, there is controversy over the correct dose and the utility of the treatment-to-goal (cholesterol, low-density lipoprotein) approach. To answer remaining ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Circulation

سال: 2020

ISSN: 0009-7322,1524-4539

DOI: 10.1161/circulationaha.119.044282